SUBSEQUENT EVENTS (Details) - USD ($)			1 Months Ended				6 Months Ended	12 Months Ended
	Jul. 19, 2017	Apr. 07, 2016	Jul. 31, 2017	Jul. 31, 2016	Jun. 27, 2016	Apr. 30, 2016	Apr. 30, 2016	Oct. 31, 2015	Apr. 01, 2016
Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from private placement		$ 38,329
Proceeds from private placement, shares		250,000					250,000	30,000,000
Common Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from private placement			$ 38,329
Proceeds from private placement, shares			250,000
Humavox [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Percentage of interest purchased in acquisition					100.00%
Total purchase price					$ 16,000,000
Percentage of Company's common stock offered as consideration for acquisition					50.00%
Period of unconditional installments					24 months
Termination date for business acquisition agreement				Jul. 29, 2016
Humavox [Member] | Warrants and options [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Percentage of interest purchased in acquisition					100.00%
Humavox [Member] | First installment amount [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Total purchase price					$ 5,500,000
Medical technology business [Member] | Subsequent Event [Member] | Scenario, Forecast [Member]
Subsequent Event [Line Items]
Consideration owed for due diligence expenditures	$ 100,000
Consideration owed for additional due diligence expenditures	100,000
Common stock issuable as consideration for business acquisition at an issue price of USD$0.22	$ 2,500,000
Common stock issuance price per share	$ 0.22
Common stock issuable as consideration at issue price of USD$0.22 subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Common stock issuable as consideration at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Issuance price per share for each milestone achieved	$ 0.22
Required capital to be raised by Company as part of acquisition agreement and as a condition to completion	$ 2,500,000
Medical technology business [Member] | Subsequent Event [Member] | Scenario, Forecast [Member] | Maximum [Member]
Subsequent Event [Line Items]
Purchase price	$ 7,500,000
PayItSimple [Member]
Subsequent Event [Line Items]
Investment amount									$ 15,000,000
Percentage purchase of interest									30.00%
Termination date for business acquisition agreement						Apr. 06, 2016
PayItSimple [Member] | Total Interest Holding [Member]
Subsequent Event [Line Items]
Percentage purchase of interest									40.00%
PayItSimple [Member] | Additional Investment [Member]
Subsequent Event [Line Items]
Investment amount									$ 7,500,000
Percentage purchase of interest									10.00%